The impact of COVID-19 on A fertility center in Indonesia: A brief report

Tjahyadi, Dian; Ropii, Bejo; Tjandraprawira, Kevin Dominique; Achmad, Yanni Melliandari; Permadi, Wiryawan; Djuwantono, Tono

doi:10.1016/j.amsu.2022.103762

Cited by 1 publication

(1 citation statement)

References 5 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…IVF clinics and fertility patients have adjusted to the 'new normal' with Covid-19 [7][8][9]. The pandemic certainly altered the cadence of research from a routine marathon to a fresh sprint [10], and this work offers a new route map through the IVF neighborhood.…”

Section: Discussionmentioning

confidence: 99%

Cross-domain research output trends in Covid-19 and the advanced reproductive technologies, 2020-2022

Sills

Wood²

2023

Preprint

View full text Add to dashboard Cite

Background: How has the research portfolio among IVF clinics been impacted by the Covid-19 pandemic? From 2020 to present, the publication output at the intersection of IVF and Covid-19 has evolved and enlarged consistently each year. Methods: This descriptive, bibliometric scoping audit gathered metadata on all publications accessioned by the U.S. National Library of Medicine under MeSH terms ‘IVF’ and ‘Covid-19’, from 2020 to 2022. Results:In April 2020, the first published reports on IVF and Covid-19 entered the medical literature; 290 authors had produced 39 papers in this domain by year end. Research output on IVF and Covid-19 accelerated in 2021 and 2022 with a total of 158 articles attributed to >1200 authors. During the three-year reference interval, Open Access (free full-text) papers accounted for more than half of all published work. Despite pandemic lockdown restrictions, international collaboration on Covid-19 research at IVF units peaked in 2021 (39.6%). Conclusions: Although IVF units were temporarily closed during quarantine, the unprecedented challenges during the pandemic did not halt published research and patient safety remained uncompromised. Reliance on letters, editorials, and committee opinions seen in the early pandemic is unlikely to recur, now that more original primary clinical data are available.

show abstract

Section: Discussionmentioning

confidence: 99%